Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer

Annals of Surgical Oncology

Volumn 19, Issue 8, 2012, Pages 2580-2589

  Bevilacqua, José Luiz B ^a,b   Kattan, Michael W ^c   Changhong, Yu ^c   Koifman, Sergio ^a   Mattos, Inês E ^a   Koifman, Rosalina J ^a   Bergmann, Anke ^d,e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c LERNER RESEARCH INSTITUTE   (United States)

^d INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^e Centro Universitario Augusto Motta UNISUAM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CLINICAL FEATURE; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; NOMOGRAM; PARTIAL MASTECTOMY; POSTOPERATIVE INFECTION; PREDICTIVE VALUE; PROBABILITY; RADIATION FIELD; SEROMA; TUMOR VOLUME;

ARM; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHEDEMA; MIDDLE AGED; NOMOGRAMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84864997672     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2290-x     Document Type: Article

References (67)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2008, Cancer incidence and mortality worldwide. IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr.
2. American Cancer Society. Cancer facts and figures, 2010. Atlanta: American Cancer Society; 2010.
3. Surveillance, Epidemiology, and End Results. Cancer of the breast (invasive)-estimated United States cancer prevalence counts on January 1, 2007, by race/ethnicity, sex and years since diagnosis (table 4.25). SEER Cancer Statistics Review, 1975-2007. http://seer.cancer.gov/csr/1975-2007/browse-csr. php?section=4&page=sect-04-table.25.html.
4. International Data Base (IDB)-World population summary. US Census Bureau, Population Division, December 11, 2010. http://www.census.gov/ipc/www/idb/ worldpopinfo.php.
5. SA McLaughlin MJ Wright KT Morris, et al. 2008 Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements J Clin Oncol. 26 5213 5219 18838709 10.1200/JCO.2008.16.3725
6. RJ Tsai LK Dennis CF Lynch LG Snetselaar GK Zamba C Scott-Conner 2009 The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors Ann Surg Oncol. 16 1959 1972 19365624 10.1245/s10434-009-0452-2
7. JL Bevilacqua MW Kattan JV Fey HS Cody III PI Borgen KJ Van Zee 2007 Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol. 25 3670 3679 17664461 10.1200/JCO.2006.08.8013
8. AC Voogd JW Coebergh OJ Repelaer van Driel, et al. 2000 The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis Breast Cancer Res Treat. 62 63 69 10989986 10.1023/A:1006447825160 1:STN:280:DC%2BD3cvkt1Snsw%3D%3D
9. TL Edwards 2000 Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania Aust N Z J Surg. 70 412 418 10843395 10.1046/j.1440-1622.2000.01839.x 1:STN:280:DC%2BD3czgtVersw%3D%3D
10. T Kuehn W Klauss M Darsow, et al. 2000 Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors Breast Cancer Res Treat. 64 275 286 11200778 10.1023/A:1026564723698 1:STN:280:DC%2BD3M7kslCksg%3D%3D
11. I Hojris J Andersen M Overgaard J Overgaard 2000 Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone Acta Oncol. 39 355 372 10987233 10.1080/028418600750013131 1:STN:280:DC%2BD3cvlsVGjsg%3D%3D
12. J Johansen J Overgaard M Blichert-Toft M Overgaard 2000 Treatment of morbidity associated with the management of the axilla in breast-conserving therapy Acta Oncol. 39 349 354 10987232 10.1080/028418600750013122 1:STN:280:DC%2BD3cvlsVCquw%3D%3D
13. P Schrenk R Rieger A Shamiyeh W Wayand 2000 Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer. 88 608 614 10649254 10.1002/(SICI)1097-0142(20000201)88: 3<608::AID-CNCR17>3.0.CO;2-K 1:STN:280:DC%2BD3c7hsFeltw%3D%3D
14. G Isaksson B Feuk 2000 Morbidity from axillary treatment in breast cancer-a follow-up study in a district hospital Acta Oncol. 39 335 336 10987230 10.1080/028418600750013104 1:STN:280:DC%2BD3cvlsVCqtQ%3D%3D
15. JA Petrek RT Senie M Peters PP Rosen 2001 Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis Cancer. 92 1368 1377 11745212 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9 1:STN:280:DC%2BD3MnpsFKjug%3D%3D
16. R Freitas Jr LFJ Ribeiro L Tala D Kajita MV Fernandes G Queiroz 2001 Lymphedema in breast cancer patients submitted to modified radical mastectomy Rev Bras Ginecol Obstet. 23 205 208 10.1590/S0100-72032001000400002
17. JM Ververs RM Roumen AJ Vingerhoets, et al. 2001 Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer Eur J Cancer. 37 991 999 11334724 10.1016/S0959-8049(01)00067-3 1:STN:280:DC%2BD3M3jvFKqug%3D%3D
18. SF Sener DJ Winchester CH Martz, et al. 2001 Lymphedema after sentinel lymphadenectomy for breast carcinoma Cancer. 92 748 752 11550143 10.1002/1097-0142(20010815)92:4<748::AID-CNCR1378>3.0.CO;2-V 1:STN:280:DC%2BD3MvpvFahsw%3D%3D
19. M Duff AD Hill G McGreal S Walsh EW McDermott NJ O'Higgins 2001 Prospective evaluation of the morbidity of axillary clearance for breast cancer Br J Surg. 88 114 117 11136322 10.1046/j.1365-2168.2001.01620.x 1:STN:280:DC%2BD3M7isFGhsw%3D%3D
20. A Herd-Smith A Russo MG Muraca MR Del Turco G Cardona 2001 Prognostic factors for lymphedema after primary treatment of breast carcinoma Cancer. 92 1783 1787 11745250 10.1002/1097-0142(20011001)92:7<1783::AID-CNCR1694>3.0. CO;2-G 1:STN:280:DC%2BD3MnpsFKksg%3D%3D
21. F Meric TA Buchholz NQ Mirza, et al. 2002 Long-term complications associated with breast-conservation surgery and radiotherapy Ann Surg Oncol. 9 543 549 12095969 10.1007/BF02573889
22. AM Almeida MAS Prado LLF Guidorizzi FP Rossini 2002 Mulheres com câncer de mama: estudo de morbidade Acta Oncol Bras. 22 263 269
23. SM Beaulac LA McNair TE Scott WW LaMorte MT Kavanah 2002 Lymphedema and quality of life in survivors of early-stage breast cancer Arch Surg. 137 1253 1257 12413312 10.1001/archsurg.137.11.1253
24. KK Swenson MJ Nissen C Ceronsky L Swenson MW Lee TM Tuttle 2002 Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer Ann Surg Oncol. 9 745 753 12374657 10.1007/BF02574496
25. LK Temple R Baron HS Cody III, et al. 2002 Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women Ann Surg Oncol. 9 654 662 12167579 10.1007/BF02574481
26. RS Rampaul K Mullinger RD Macmillan, et al. 2003 Incidence of clinically significant lymphoedema as a complication following surgery for primary operable breast cancer Eur J Cancer. 39 2165 2167 14522373 10.1016/S0959-8049(03)00539-2 1:STN:280:DC%2BD3svmtVGmuw%3D%3D
27. M Deutsch JC Flickinger 2003 Arm edema after lumpectomy and breast irradiation Am J Clin Oncol. 26 229 231 12796589
28. MP Schijven AJ Vingerhoets HJ Rutten, et al. 2003 Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy Eur J Surg Oncol. 29 341 350 12711287 10.1053/ejso.2002.1385 1:STN:280: DC%2BD3s7pt1ejuw%3D%3D
29. KP Yap DR McCready S Narod LA Manchul M Trudeau A Fyles 2003 Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma Cancer. 97 1369 1375 12627499 10.1002/cncr.11218
30. M Golshan WJ Martin K Dowlatshahi 2003 Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection Am Surg. 69 209 211 12678476
31. DK Blanchard JH Donohue C Reynolds CS Grant 2003 Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer Arch Surg. 138 482 487 12742949 10.1001/archsurg.138.5.482
32. U Veronesi G Paganelli G Viale, et al. 2003 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med. 349 546 553 12904519 10.1056/NEJMoa012782
33. TE Goffman C Laronga L Wilson D Elkins 2004 Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery Breast J. 10 405 411 15327493 10.1111/j.1075-122X. 2004.21411.x
34. SV Deo S Ray GK Rath, et al. 2004 Prevalence and risk factors for development of lymphedema following breast cancer treatment Indian J Cancer. 41 8 12 15105573 1:STN:280:DC%2BD2c3gslCluw%3D%3D
35. C Ozaslan B Kuru 2004 Lymphedema after treatment of breast cancer Am J Surg. 187 69 72 14706589 10.1016/j.amjsurg.2002.12.003
36. AW Silberman C McVay JS Cohen, et al. 2004 Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer Ann Surg. 240 1 6 15213610 10.1097/01.sla.0000129358.80798.62
37. J Armer MR Fu JM Wainstock E Zagar LK Jacobs 2004 Lymphedema following breast cancer treatment, including sentinel lymph node biopsy Lymphology. 37 73 91 15328760 1:STN:280:DC%2BD2cvitlensw%3D%3D
38. P van der Veen N De Voogdt P Lievens W Duquet J Lamote R Sacre 2004 Lymphedema development following breast cancer surgery with full axillary resection Lymphology. 37 206 208 15693539
39. A Bergmann 2004 Diagnóstico de linfedema: análise dos métodos empregados na avaliação do membro superior após linfadenectomia axilar para tratamento do câncer de mama Rev Bras Cancerol. 50 311 320
40. A Bergmann RJ Koifman MJP Ribeiro IE Mattos 2007 Upper limb lymphedema following breast cancer surgery: prevalence and associated factors Lymphology. 40 Suppl. 96 106
41. Bergmann A. Incidência e fatores de risco do linfedema após tratamento cirúrgico para câncer de mama: Estudo de uma coorte hospitalar. Rio de Janiero: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz; 2005.
42. M Leidenius M Leivonen J Vironen K von Smitten 2005 The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance J Surg Oncol. 92 23 31 16180231 10.1002/jso.20373 1:STN:280:DC%2BD2Mrhs1SmtQ%3D%3D
43. R Rönkä K von Smitten T Tasmuth M Leidenius 2005 One-year morbidity after sentinel node biopsy and breast surgery Breast. 14 28 36 15695078 10.1016/j.breast.2004.09.010
44. B Clark J Sitzia W Harlow 2005 Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study QJM. 98 343 348 15820971 10.1093/qjmed/hci053 1:STN:280:DC%2BD2M3gtVKktw%3D%3D
45. RE Mansel L Fallowfield M Kissin, et al. 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst. 98 599 609 16670385 10.1093/jnci/djj158
46. I Langer U Guller G Berclaz, et al. 2007 Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients Ann Surg. 245 452 461 17435553 10.1097/01.sla.0000245472.47748.ec
47. A Lucci LM McCall PD Beitsch, et al. 2007 Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 J Clin Oncol. 25 3657 3663 17485711 10.1200/JCO.2006.07.4062
48. SA McLaughlin MJ Wright KT Morris, et al. 2008 Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors J Clin Oncol. 26 5220 5226 18838708 10.1200/JCO.2008.16.3766
49. JM Armer ME Radina D Porock SD Culbertson 2003 Predicting breast cancer-related lymphedema using self-reported symptoms Nurs Res. 52 370 379 14639083 10.1097/00006199-200311000-00004
50. HA Bani PA Fasching MM Lux, et al. 2007 Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit Patient Educ Couns. 66 311 318 17331692 10.1016/j.pec.2007.01.004
51. Clark GM. Prognostic and Predictive Factors. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins; 1996. p. 461-85.
52. JJ Coen AG Taghian LA Kachnic SI Assaad SN Powell 2003 Risk of lymphedema after regional nodal irradiation with breast conservation therapy Int J Radiat Oncol Biol Phys. 55 1209 1215 12654429 10.1016/S0360-3016(02)04286-4
53. CS Hinrichs NL Watroba H Rezaishiraz, et al. 2004 Lymphedema secondary to postmastectomy radiation: incidence and risk factors Ann Surg Oncol. 11 573 580 15172932 10.1245/ASO.2004.04.017
54. K Johansson K Ohlsson C Ingvar M Albertsson C Ekdahl 2002 Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study Lymphology. 35 59 71 12081053 1:STN:280:DC%2BD38zjvFahsQ%3D%3D
55. S Langer JM Guenther PI Haigh LA DiFronzo 2004 Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma Am Surg. 70 881 885 15529842
56. J Mathew L Barthelmes S Neminathan D Crawford 2006 Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery Eur J Surg Oncol. 32 729 732 16777367 10.1016/j.ejso.2006.04.019 1:STN:280: DC%2BD28rhtV2ksg%3D%3D
57. KA Meeske J Sullivan-Halley AW Smith, et al. 2009 Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women Breast Cancer Res Treat. 113 383 391 18297429 10.1007/s10549-008-9940-5
58. AH Moskovitz BO Anderson RS Yeung DR Byrd TJ Lawton RE Moe 2001 Axillary web syndrome after axillary dissection Am J Surg. 181 434 439 11448437 10.1016/S0002-9610(01)00602-X 1:STN:280:DC%2BD3Mzpslaitw%3D%3D
59. JR Casley-Smith 1994 Measuring and representing peripheral oedema and its alterations Lymphology. 27 56 70 8078362 1:STN:280:DyaK2czlvFartw%3D%3D
60. D Clarke A Martinez RS Cox DR Goffinet 1982 Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy Cancer. 49 2295 2299 7074546 10.1002/1097-0142(19820601)49: 11<2295::AID-CNCR2820491116>3.0.CO;2-G 1:STN:280:DyaL387osVSqsg%3D%3D
61. Mathers C, Fat DM, Boerma JT, World Health Organization. The global burden of disease 2004 update. Geneva: World Health Organization; 2008.
62. ED Pisano C Gatsonis E Hendrick, et al. 2005 Diagnostic performance of digital versus film mammography for breast-cancer screening N Engl J Med. 353 1773 1783 16169887 10.1056/NEJMoa052911 1:CAS:528:DC%2BD2MXhtFKrtLnN
63. AE Giuliano L McCall P Beitsch, et al. 2010 Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg. 252 426 432 20739842
64. AE Giuliano KK Hunt KV Ballman, et al. 2011 Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA. 305 569 575 21304082 10.1001/jama.2011.90 1:CAS:528:DC%2BC3MXhvVymtrg%3D
65. WP Weber M Barry MM Stempel, et al. 2012 A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol. 19 225 232 21647763 10.1245/s10434-011-1823-z
66. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology, version 2, 2011. http://www.nccn.org/.
67. A Baker H Kim JL Semple, et al. 2010 Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy Breast Cancer Res. 12 R70 20825671 10.1186/bcr2638